|
On April 25, 2008 Actavis Totowa LLC, a subdivision of Actavis Group initiated a Class I nationwide recall of Digitek (digoxin tablets, USP, all strengths) for oral use. Digitek was recalled due to the possibility that extra thick tablets with twice the appropriate levels of active ingredients may have been commercially released. Generally, patients take Digitek to help with heart failure and abnormal heart rhythms. Administering these double strength tablets poses a risk of digitalis toxicity in patients with renal failure. The symptoms of such high toxicity are nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia, and even death.
Actavis has asked doctors and pharmacies to look back as far as 2006 to determine who may have taken the dangerous medication. In the meantime, Actavis has stopped making Digitek® and is working to “address and identify the cause of what led to the recall.” At least one newspaper has reported that individuals have experienced illnesses or injuries potentially due to Digitek.
Injured Person Information:
Accident / Injury Information:
Case Description*
Please explain exactly what happened, trying to state
as thoroughly as possible who you believe was responsible
and why you believe that person was negligent:
|
Please explain the full extent of the victims injuries:
|
Comments / Additional Information
Is there anything else that would assist us in
understanding the facts of your case?
|
| 
